Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

ARPA-H awards more than $100M to biosensor development projects

5 October 2026 · By · Wire by Fusion42

Published

5 October 2026

Topic

operational-macro

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at medtechdive.com →

◆ Verified

Fusion42 · 6 October 2026 · Fusion42 review

ARPA-H awarded more than $100 million to four organizations developing biosensors for heart disease, inflammation, and perimenopause monitoring.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

ARPA-H’s funding surge unlocks opportunities for Medtech founders to advance biosensor solutions addressing chronic conditions, signalling increased market attention and public investment in digital diagnostics.

◆ Coverage

1 source · 5 Oct 2026

◆ Related on Wire

◆ Topics

Medtechbiosensorsfundinghealthtechheart-diseaseARPA-H